CTS (CTS) Investor presentation summary

Business overview and market positioning

• Designs and manufactures custom engineered solutions for sensing, connectivity, and motion across global markets, with $555M in LTM revenue and 23% adjusted EBITDA margin.

• Revenue is diversified: 43% transportation, 26% industrial, 16% medical, and 15% aerospace & defense.

• Global footprint with 58% of sales in North America, 21% in Europe, and 21% in Asia.

• Focuses on automation, healthcare innovation, sustainability, and electrification as key growth drivers.

Growth strategy and execution

• Targets 10% annual growth through a mix of organic initiatives and strategic M&A.

• Leverages deep technical expertise and long-standing customer relationships to drive mid-single digit organic growth.

• Strategic M&A enhances technology, expands product lines, and strengthens customer relationships, contributing ~5% of sales growth.

• Strong balance sheet and cash flow support ongoing investments and acquisitions.

End market performance and innovation

• Industrial market LTM revenue at $145M (+14% YOY), driven by automation and sustainability trends.

• Medical market LTM revenue at $90M (+25% YOY), with growth in ultrasound and wireless pacemaker applications.

• Aerospace & defense LTM revenue at $84M (+15% YOY), benefiting from increased defense spending and EU expansion.

• Transportation LTM revenue at $236M, with >95% of portfolio powertrain agnostic and new product awards secured.